Jentzen W - Search Results

1

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K, Pöttgen C. Guberina M, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1439-1447. doi: 10.1007/s00259-019-4270-x. Epub 2019 Feb 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30710323 Clinical Trial.

2

FDG-PET/CT in re-staging of patients with lymphoma.

Freudenberg LS, Antoch G, Schütt P, Beyer T, Jentzen W, Müller SP, Görges R, Nowrousian MR, Bockisch A, Debatin JF. Freudenberg LS, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):325-9. doi: 10.1007/s00259-003-1375-y. Epub 2003 Nov 26. Eur J Nucl Med Mol Imaging. 2004. PMID: 14647988 Clinical Trial.

3

124I-PET dosimetry in advanced differentiated thyroid cancer: therapeutic impact.

Freudenberg LS, Jentzen W, Görges R, Petrich T, Marlowe RJ, Knust J, Bockisch A. Freudenberg LS, et al. Among authors: jentzen w. Nuklearmedizin. 2007;46(4):121-8. Nuklearmedizin. 2007. PMID: 17690789 Clinical Trial.

4

Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.

Jentzen W, Weise R, Kupferschläger J, Freudenberg L, Brandau W, Bares R, Burchert W, Bockisch A. Jentzen W, et al. Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):611-23. doi: 10.1007/s00259-007-0554-7. Epub 2007 Oct 10. Eur J Nucl Med Mol Imaging. 2008. PMID: 17929014

5

Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET.

Freudenberg LS, Jentzen W, Müller SP, Bockisch A. Freudenberg LS, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):502-8. doi: 10.1007/s00259-007-0601-4. Epub 2007 Nov 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18026950

6

Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.

Freudenberg LS, Antoch G, Frilling A, Jentzen W, Rosenbaum SJ, Kühl H, Bockisch A, Görges R. Freudenberg LS, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7. doi: 10.1007/s00259-007-0634-8. Epub 2008 Jan 12. Eur J Nucl Med Mol Imaging. 2008. PMID: 18193222

7

A novel view on dosimetry-related radionuclide therapy: presentation of a calculatory model and its implementation for radioiodine therapy of metastasized differentiated thyroid carcinoma.

Stahl AR, Freudenberg L, Bockisch A, Jentzen W. Stahl AR, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1147-55. doi: 10.1007/s00259-009-1077-1. Epub 2009 Feb 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19247651

8

Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.

Jentzen W, Hobbs RF, Stahl A, Knust J, Sgouros G, Bockisch A. Jentzen W, et al. Eur J Nucl Med Mol Imaging. 2010 May;37(5):884-95. doi: 10.1007/s00259-009-1351-2. Epub 2010 Jan 13. Eur J Nucl Med Mol Imaging. 2010. PMID: 20069293 Free PMC article.

9

The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.

Jentzen W, Balschuweit D, Schmitz J, Freudenberg L, Eising E, Hilbel T, Bockisch A, Stahl A. Jentzen W, et al. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2298-306. doi: 10.1007/s00259-010-1532-z. Epub 2010 Jul 13. Eur J Nucl Med Mol Imaging. 2010. PMID: 20625723

10

Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons.

Freudenberg LS, Jentzen W, Petrich T, Frömke C, Marlowe RJ, Heusner T, Brandau W, Knapp WH, Bockisch A. Freudenberg LS, et al. Among authors: jentzen w. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2267-76. doi: 10.1007/s00259-010-1565-3. Epub 2010 Jul 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20661558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters